individualized according to each individual patient's pretreatment and clinical characteristics.
Pretreatment with the M2 receptor agonist pilocarpine increased histamine PC20, at baseline, indicating normal function of the neuronal M2 muscarinic receptor.
The orthodontist compiles pretreatment records that are used for diagnosis, determining the course of treatment, and measuring the progress of treatment.
CONCLUSIONS: Pretreatment alpha-fetoprotein level, tumor-to-normal uptake ratio of yttrium-90 microspheres and the number of treatments determine survival duration.
elevated above the pretreatment levels during ERT.